Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sitagliptin versus sulfonylurea on endothelial function and oxidative stress in type 2 diabetes
2012-000152-34Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoints: Endothelial function and oxidative stress and Markers of inflammation and platelet function. Started Mar 2012; status: active.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-000152-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000152-34.